These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35896684)

  • 1. The maximum length of T2-dark intraplacental bands may help predict intraoperative haemorrhage in pregnant women with placenta accreta spectrum (PAS).
    Wu X; Zhou R; Lin M; Li Y; Ying W; Li L; Ji W; Zheng K
    Abdom Radiol (NY); 2022 Oct; 47(10):3594-3603. PubMed ID: 35896684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraplacental Fetal Vessel Diameter May Help Predict for Placental Invasiveness in Pregnant Women at High Risk for Placenta Accreta Spectrum Disorders.
    Bourgioti C; Konstantinidou AE; Zafeiropoulou K; Antoniou A; Fotopoulos S; Theodora M; Daskalakis G; Nikolaidou ME; Tzavara C; Letsika A; Martzoukos EA; Moulopoulos LA
    Radiology; 2021 Feb; 298(2):403-412. PubMed ID: 33231529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of MRI-based scoring models for predicting placental invasiveness in high-risk women for placenta accreta spectrum.
    Liu Q; Zhou W; Yan Z; Li D; Lou T; Yuan Y; Rong P; Feng Z
    Eur Radiol; 2024 Feb; 34(2):957-969. PubMed ID: 37589907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraplacental T2-hypointense bands may help predict placental invasion depth and postpartum hemorrhage in placenta accrete spectrum disorders in high-risk gravid patients.
    Hu Y; Wang Y; Weng Q; Wu X; Xia S; Wang H; Cheng X; Mao C; Li X; Zhou Z; Chen C; Xu M; Wang Z; Ji J
    Magn Reson Imaging; 2022 Dec; 94():73-79. PubMed ID: 36116713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of super resolution reconstruction MRI for surgical planning in Placenta accreta spectrum disorder: Case series.
    Mufti N; Chappell J; O'Brien P; Attilakos G; Irzan H; Sokolska M; Narayanan P; Gaunt T; Humphries PD; Patel P; Whitby E; Jauniaux E; Hutchinson JC; Sebire NJ; Atkinson D; Kendall G; Ourselin S; Vercauteren T; David AL; Melbourne A
    Placenta; 2023 Oct; 142():36-45. PubMed ID: 37634372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel MRI-based diagnostic model for predicting placenta accreta spectrum.
    Xia J; Hu Y; Huang Z; Chen S; Huang L; Ruan Q; Zhao C; Deng S; Wang M; Zhang Y
    Magn Reson Imaging; 2024 Jun; 109():34-41. PubMed ID: 38408691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRI prognosticators for adverse maternal and neonatal clinical outcome in patients at high risk for placenta accreta spectrum (PAS) disorders.
    Bourgioti C; Zafeiropoulou K; Fotopoulos S; Nikolaidou ME; Theodora M; Daskalakis G; Tzavara C; Chatoupis K; Panourgias E; Antoniou A; Konstantinidou A; Moulopoulos LA
    J Magn Reson Imaging; 2019 Aug; 50(2):602-618. PubMed ID: 30578609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Magnetic Resonance Imaging of the Lower Uterine Segment in Pregnant Women with Central Placenta Previa with and without Placenta Accreta Spectrum from a Single Center.
    Hou S; Song Y; Wu J; Zhou L; Kang S; Chen X; Zhang L; Lu Y; Yue Y
    Med Sci Monit; 2021 Oct; 27():e932759. PubMed ID: 34675167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasound and magnetic resonance imaging in the diagnosis of clinically significant placenta accreta spectrum disorders.
    Cavalli C; Maggi C; Gambarini S; Fichera A; Santoro A; Grazioli L; Prefumo F; Odicino FE; Fratelli N
    J Perinat Med; 2022 Mar; 50(3):277-285. PubMed ID: 34854274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of placenta accreta spectrum in patients with placenta previa using clinical risk factors, ultrasound and magnetic resonance imaging findings.
    Romeo V; Verde F; Sarno L; Migliorini S; Petretta M; Mainenti PP; D'Armiento M; Guida M; Brunetti A; Maurea S
    Radiol Med; 2021 Sep; 126(9):1216-1225. PubMed ID: 34156592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The MRI estimations of placental volume, T2 dark band volume, and cervical length correlate with massive hemorrhage in patients with placenta accreta spectrum disorders.
    Yue Y; Song Y; Zhu L; Xu D; Li Z; Liu C; Liang B; Lu Y
    Abdom Radiol (NY); 2024 Jul; 49(7):2525-2533. PubMed ID: 38451265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of placenta accreta spectrum in patients with placenta previa using a clinical, US and MRI combined model: A retrospective study with external validation.
    Maurea S; Verde F; Romeo V; Stanzione A; Mainenti PP; Raia G; Barbuto L; Iacobellis F; Santangelo F; Sarno L; Migliorini S; Petretta M; D'Armiento M; De Dominicis G; Santangelo C; Guida M; Romano L; Brunetti A
    Eur J Radiol; 2023 Nov; 168():111116. PubMed ID: 37801998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of postpartum haemorrhage for placenta accreta: Is measurement of myometrium thickness and dark intraplacental bands using MRI helpful?
    Chen X; Ming Y; Xu H; Xin Y; Yang L; Liu Z; Han Y; Huang Z; Liu Q; Zhang J
    BMC Med Imaging; 2022 Oct; 22(1):179. PubMed ID: 36253716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting Placenta Accreta Spectrum Disorders in a Cohort of Pregnant Patients in the North-East Region of Romania-Diagnostic Accuracy of Ultrasound and Magnetic Resonance Imaging.
    Haba RM; Pristavu AI; Cobzeanu ML; Carauleanu A; Sadiye Scripcariu I; Vasilache IA; Minciuna DA; Negru D; Socolov DG
    Diagnostics (Basel); 2022 Sep; 12(9):. PubMed ID: 36140531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Ultrasound and MRI in Diagnosis of Severe Placenta Accreta Spectrum Disorder: An Intraindividual Assessment With Emphasis on Placental Bulge.
    Thiravit S; Ma K; Goldman I; Chanprapaph P; Jha P; Hippe DS; Dighe M
    AJR Am J Roentgenol; 2021 Dec; 217(6):1377-1388. PubMed ID: 34037411
    [No Abstract]   [Full Text] [Related]  

  • 16. Prenatal planning of placenta previa: diagnostic accuracy of a novel MRI-based prediction model for placenta accreta spectrum (PAS) and clinical outcome.
    Delli Pizzi A; Tavoletta A; Narciso R; Mastrodicasa D; Trebeschi S; Celentano C; Mastracchio J; Cianci R; Seccia B; Marrone L; Liberati M; Cotroneo AR; Caulo M; Basilico R
    Abdom Radiol (NY); 2019 May; 44(5):1873-1882. PubMed ID: 30600374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective evaluation of impact of post-Cesarean section uterine scarring in perinatal diagnosis of placenta accreta spectrum disorder.
    Hussein AM; Elbarmelgy RA; Elbarmelgy RM; Thabet MM; Jauniaux E
    Ultrasound Obstet Gynecol; 2022 Apr; 59(4):474-482. PubMed ID: 34225385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Society of Abdominal Radiology (SAR) and European Society of Urogenital Radiology (ESUR) joint consensus statement for MR imaging of placenta accreta spectrum disorders.
    Jha P; Pōder L; Bourgioti C; Bharwani N; Lewis S; Kamath A; Nougaret S; Soyer P; Weston M; Castillo RP; Kido A; Forstner R; Masselli G
    Eur Radiol; 2020 May; 30(5):2604-2615. PubMed ID: 32040730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic accuracy of magnetic resonance imaging in assessing placental adhesion disorder in patients with placenta previa: Correlation with histological findings.
    Maurea S; Romeo V; Mainenti PP; Ginocchio MI; Frauenfelder G; Verde F; Liuzzi R; D'Armiento M; Sarno L; Morlando M; Petretta M; Martinelli P; Brunetti A
    Eur J Radiol; 2018 Sep; 106():77-84. PubMed ID: 30150055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percreta score to differentiate between placenta accreta and placenta percreta with ultrasound and MR imaging.
    Pain FA; Dohan A; Grange G; Marcellin L; Uzan-Augui J; Goffinet F; Soyer P; Tsatsaris V
    Acta Obstet Gynecol Scand; 2022 Oct; 101(10):1135-1145. PubMed ID: 35822244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.